Free Access
Genet. Sel. Evol.
Volume 35, Number Suppl. 1, 2003
Second International Symposium on Candidate Genes for Animal Health
Page(s) S51 - S65


  1. Davenport M.P., Hill A.V., Reverse immunogenetics: from HLA-disease associations to vaccine candidates, Mol. Med. Today 2 (1996) 38-45.
  2. Fahmy T.M., Bieler J.G., Edidin M., Schneck J.P., Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen, Immunity 14 (2001) 135-143.
  3. Fraser D.C., Craigmile S., Campbell J.D., et al., Functional expression of a cattle MHC class II DR-like antigen on mouse L cells, Immunogenetics 43 (1996) 296-303.
  4. Glass E.J., Spooner R.L., Generation and characterisation of bovine antigen-specific T cell lines, J. Immunol. Methods 128 (1990) 267-275.
  5. Godkin A.J., Davenport M.P., Willis A., Jewell D.P., Hill A.V., Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection, J. Immunol. 161 (1998) 850-858.
  6. Grogan J.L., Mohrs M., Harmon B., et al., Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets, Immunity 14 (2001) 205-215.
  7. Haghparast A., Wauben M.H., Grosfeld-Stulemeyer M.C., van Kooten P., Hensen E.J., Selection of T-cell epitopes from foot-and-mouth disease virus reflects the binding affinity to different cattle MHC class II molecules, Immunogenetics 51 (2000) 733-742.
  8. Hammer J., Takacs B., Sinigaglia F., Identification of a motif for HLA-DR1 binding peptides using M13 display libraries, J. Exp. Med. 176 (1992) 1007-1013.
  9. Hasbold J., Gett A.V., Rush J.S., et al., Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester, Immunol. Cell Biol. 77 (1999) 516-522.
  10. Hill A.V., The immunogenetics of human infectious diseases, Annu. Rev. Immunol. 16 (1998) 593-617.
  11. Janssen E.M., van Oosterhout A.J., van Rensen A.J., et al., Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide, J. Immunol. 164 (2000) 580-588.
  12. Krupnick A.S., Kreisel D., Szeto W.Y., et al., Multiparameter flow cytometric approach for simultaneous evaluation of T lymphocyte-endothelial cell interactions, Cytometry 46 (2001) 271-280.
  13. Kumar V., Bhardwaj V., Soares L., et al., Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells, Proc. Natl. Acad. Sci. USA 92 (1995) 9510-9540.
  14. Laouar Y., Crispe I.N., Functional flexibility in T cells: independent regulation of CD4+ T cell proliferation and effector function in vivo, Immunity 13 (2000) 291-301.
  15. Maillard J.C., Martinez D., Bensaid A., An amino acid sequence coded by the exon 2 of the BoLA DRB3 gene associated with a BoLA class I specificity constitutes a likely genetic marker of resistance to dermatophilosis in Brahman zebu cattle of Martinique (FWI), Ann. N.Y. Acad. Sci. 791 (1996) 185-197.
  16. McFarland B.J., Beeson C., Binding interactions between peptides and proteins of the class II major histocompatibility complex, Med. Res. Rev. 22 (2002) 168-203.
  17. McFarland B.J., Sant A.J., Lybrand T.P., Beeson C., Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers, Biochemistry 38 (1999) 16663-16670.
  18. Morgenstern B., DIALIGN 2: improvement of the segment-to-segment approach to multiple sequence alignment, Bioinformatics 15 (1999) 211-218.
  19. Murray J.S., How the MHC selects Th1/Th2 immunity, Immunol. Today 19 (1998) 157-163.
  20. Rogers P.R., Croft M., Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance, J. Immunol. 163 (1999) 1205-1213.
  21. Romagnani S., T-cell subsets (Th1 versus Th2), Ann. Allergy Asthma Immunol. 85 (2000) 9-18.
  22. Sette A., Sidney J., Albertson M., et al., A novel approach to the generation of high affinity class II-binding peptides, J. Immunol. 145 (1990) 1809-1813.
  23. Sharif S., Mallard B.A., Characterization of naturally processed peptides presented by the bovine major histocompatibility complex class II DR molecule, in: Proceedings of the 27th International Conference on Animal Genetics, 22-26 July 2000, St. Paul, Minnesota, p. 68.
  24. Sharif S., Mallard B.A., Wilkie B.N., et al., Associations of the bovine major histocompatibility complex DRB3 (BoLA- DRB3) alleles with occurrence of disease and milk somatic cell score in Canadian dairy cattle, Anim. Genet. 29 (1998) 185-193.
  25. Sharif S., Mallard B.A., Sargeant J.M., Presence of glutamine at position 74 of pocket 4 in the BoLA-DR antigen binding groove is associated with occurrence of clinical mastitis caused by Staphylococcus species, Vet. Immunol. Immunopathol. 76 (2000) 231-238.
  26. Sharif S., Mallard B.A., Wilkie B.N., Characterization of naturally processed and presented peptides associated with bovine MHC (BoLA) DR molecules, Anim. Genet. 34 (2003) 116-123.
  27. Shortman K., Williams N., Adams P., The separation of different cell classes from lymphoid organs. V. Simple procedures for the removal of cell debris. Damaged cells and erythroid cells from lymphoid cell suspensions, J. Immunol. Methods 1 (1972) 273-287.
  28. Stern L.J., Brown J.H., Jardetzky T.S., et al., Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide, Nature 368 (1994) 215-221.
  29. Valitutti S., Muller S., Salio M., Lanzavecchia A., Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation, J. Exp. Med. 185 (1997) 1859-1864.
  30. Viola A., Lanzavecchia A., T cell activation determined by T cell receptor number and tunable thresholds, Science 273 (1996) 104-106.
  31. Wagter L.C., Mallard B.A., Wilkie B.N., et al., A quantitative approach to classifying Holstein cows based on antibody responsiveness and its relationship to peripartum mastitis occurrence, J. Dairy Sci. 83 (2000) 488-498.
  32. Wu S., Gorski J., Polymorphism at beta 85 and not beta 86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism, Int. Immunol. 9 (1997) 1495-1502.
  33. Xu A., van Eijk M.J., Park C., Lewin H.A., Polymorphism in BoLA-DRB3 exon 2 correlates with resistance to persistent lymphocytosis caused by bovine leukemia virus, J. Immunol. 151 (1993) 6977-6985.


Copyright INRA, EDP Sciences